Skip to content

Azra AI

1 viewer · 30d

Total raised

$10.5M

+$10.5M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $10.5M
ROUNDS
1
INVESTORS
73
FOUNDED
2021
HQ
Franklin, TN
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

Azra AI is a Franklin, Tennessee healthcare software company whose AI platform reads pathology and radiology reports in real time to surface cancer diagnoses and suspicious incidental findings. It classifies findings by primary site and routes patients to navigators and care teams so treatment starts sooner, layering closed-loop workflows on top of the hospital's existing EHR, which remains the system of record. The company says its SaaS clinical intelligence product is used by more than 200 hospitals and cancer centers. Coverage has extended beyond oncology into radiology, cardiology, emergency medicine and clinical research programs.

What sets it apart

Real-time AI detection of cancer and incidental findings wired directly into accountable patient-navigation workflows and bidirectional EHR integration, rather than a standalone analytics report.

Funding history

1 round
EquityApr 24, 2026
Form D
+$10.5M$10.5M total

Latest SEC filings

via EDGAR · CIK 0002050868
Form D · Apr 24, 2026View on EDGAR

Products

1 tracked

Azra AI oncology platform

Clinical intelligence SaaS

An enterprise patient management and clinical intelligence platform that overlays a health system's EHR, using AI to identify cancer diagnoses and incidental findings in pathology and radiology reports and drive patients through defined care pathways.

  • Real-time AI analysis of pathology and radiology reports
  • Detection and classification of incidental findings by primary site
  • Automated routing to cancer navigators and care teams
  • Closed-loop care pathway workflows with measurable accountability